0.22
price down icon3.64%   -0.0083
after-market Dopo l'orario di chiusura: .22
loading
Precedente Chiudi:
$0.2283
Aprire:
$0.211
Volume 24 ore:
387.45K
Relative Volume:
0.22
Capitalizzazione di mercato:
$8.08M
Reddito:
-
Utile/perdita netta:
$-40.10M
Rapporto P/E:
-0.0233
EPS:
-9.46
Flusso di cassa netto:
$-36.99M
1 W Prestazione:
-14.40%
1M Prestazione:
+1.20%
6M Prestazione:
-29.49%
1 anno Prestazione:
-86.50%
Intervallo 1D:
Value
$0.211
$0.224
Intervallo di 1 settimana:
Value
$0.211
$0.2689
Portata 52W:
Value
$0.1281
$1.7277

Mustang Bio Inc Stock (MBIO) Company Profile

Name
Nome
Mustang Bio Inc
Name
Telefono
(781) 652-4500
Name
Indirizzo
377 PLANTATION STREET, WORCESTER, NY
Name
Dipendente
80
Name
Cinguettio
@Mustang_Bio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
MBIO's Discussions on Twitter

Confronta MBIO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
MBIO 0.22 8.08M 0 -40.10M -36.99M -9.46
VRTX 467.01 119.87B 10.63B -479.80M -1.35B 13.33
REGN 762.00 83.27B 13.85B 4.65B 3.32B 35.06
ARGX 567.90 33.96B 1.86B -40.29M -1.28B -4.16
ALNY 232.27 30.18B 2.09B -332.26M 16.06M -4.14
BNTX 101.87 24.42B 3.30B -501.07M 1.03B 11.54

Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-05-18 Iniziato BTIG Research Buy
2020-10-02 Iniziato B. Riley FBR Buy
2019-11-20 Iniziato Cantor Fitzgerald Overweight
2019-08-13 Iniziato H.C. Wainwright Buy
2019-06-21 Iniziato Cantor Fitzgerald Overweight
2017-12-21 Iniziato Oppenheimer Outperform
Mostra tutto

Mustang Bio Inc Borsa (MBIO) Ultime notizie

pulisher
Nov 15, 2024

Mustang Bio's Interim CFO Resigns After 10 Months - MarketWatch

Nov 15, 2024
pulisher
Nov 15, 2024

Mustang Bio Faces Nasdaq Delisting and Leadership Changes - TipRanks

Nov 15, 2024
pulisher
Nov 15, 2024

Mustang Bio, Inc. Announces CFO Changes - Marketscreener.com

Nov 15, 2024
pulisher
Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Mustang Bio Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Fortress Biotech Inc. (FBIOP) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 12, 2024

Mustang Bio gets extension for Nasdaq compliance By Investing.com - Investing.com South Africa

Nov 12, 2024
pulisher
Nov 12, 2024

Mustang Bio gets extension for Nasdaq compliance - Investing.com

Nov 12, 2024
pulisher
Nov 12, 2024

Mustang Bio Receives Positive Listing Determination from Nasdaq - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Mustang Bio Secures Critical Nasdaq Extension, Faces January 2025 Deadline for $1 Compliance | MBIO Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 10, 2024

Virus Therapy Gets Orphan Drug Designation for Glioma Treatment - www.oncnursingnews.com/

Nov 10, 2024
pulisher
Nov 08, 2024

Mustang Bio Inc (MBIO) Quarterly 10-Q Report - Quartzy

Nov 08, 2024
pulisher
Nov 08, 2024

Mustang Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 08, 2024
pulisher
Nov 08, 2024

Mustang Bio’s MB-108 receives FDA orphan drug status for glioma treatment - Yahoo Finance

Nov 08, 2024
pulisher
Nov 07, 2024

Toll Brothers Inc (TOL-N) QuotePress Release - The Globe and Mail

Nov 07, 2024
pulisher
Nov 07, 2024

Mustang Bio gains FDA Orphan Drug Status for glioma treatment - Investing.com India

Nov 07, 2024
pulisher
Nov 07, 2024

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for - GlobeNewswire

Nov 07, 2024
pulisher
Nov 07, 2024

Mustang Bio gains FDA Orphan Drug Status for glioma treatment By Investing.com - Investing.com UK

Nov 07, 2024
pulisher
Nov 07, 2024

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma - Yahoo Finance

Nov 07, 2024
pulisher
Nov 06, 2024

Mustang Bio sets annual meeting date, deadlines for proposals - Investing.com

Nov 06, 2024
pulisher
Nov 06, 2024

Everquote Inc Cl A (EVER-Q) QuotePress Release - The Globe and Mail

Nov 06, 2024
pulisher
Nov 01, 2024

Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace

Nov 01, 2024
pulisher
Oct 27, 2024

Data Readouts At EHA Congress 2021 (APTO, XFOR, GBT, CRIS…) - RTTNews

Oct 27, 2024
pulisher
Oct 26, 2024

Mustang Bio Secures $4M through Strategic Warrant Agreement - Yahoo Finance

Oct 26, 2024
pulisher
Oct 26, 2024

Revance Therapeutics Inc’s (RVNC) Stock Is Harder To Predict Than You Think - Stocks Register

Oct 26, 2024
pulisher
Oct 25, 2024

Mustang Bio, Inc. Appoints David Jin as A Member of the Board - Marketscreener.com

Oct 25, 2024
pulisher
Oct 25, 2024

Mustang Bio secures $4 million from warrant exercises - Investing.com India

Oct 25, 2024
pulisher
Oct 24, 2024

Mustang Bio secures $4 million from warrant exercises By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 24, 2024

Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds - GlobeNewswire

Oct 24, 2024
pulisher
Oct 23, 2024

Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket - Benzinga

Oct 23, 2024
pulisher
Oct 14, 2024

Chimeric Antigen Receptor T (CAR-T) Cells Market Research Analysis 2024-2033 | Growth, Size, Analysis, Insi... - WhaTech

Oct 14, 2024
pulisher
Oct 09, 2024

Investor’s Toolkit: Key Ratios for Assessing Mustang Bio Inc (MBIO)’s Performance - The Dwinnex

Oct 09, 2024
pulisher
Sep 30, 2024

A stock that deserves closer examination: Mustang Bio Inc (MBIO) - US Post News

Sep 30, 2024
pulisher
Sep 27, 2024

Why Establishment Labs Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket - MSN

Sep 27, 2024
pulisher
Sep 26, 2024

Mustang Bio Inc (MBIO) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle

Sep 26, 2024
pulisher
Sep 26, 2024

There is no doubt that Mustang Bio Inc (MBIO) ticks all the boxes. - SETE News

Sep 26, 2024
pulisher
Sep 25, 2024

Marshall Wace LLP Has $92.82 Million Position in StoneCo Ltd. (NASDAQ:STNE) - MarketBeat

Sep 25, 2024
pulisher
Sep 24, 2024

Wave Life Sciences Stock Surges On Promising Interim Data From Mid-Stage Study Of Muscular Disorder Drug - Yahoo Finance

Sep 24, 2024
pulisher
Sep 24, 2024

Market Update: Mustang Bio Inc (MBIO) Sees Negative Movement, Closing at 0.21 - The Dwinnex

Sep 24, 2024
pulisher
Sep 23, 2024

Mustang Bio (MBIO) Stock Price, News & Analysis - MarketBeat

Sep 23, 2024
pulisher
Sep 20, 2024

Wild mustangs available for adoption in Cullman County - WVTM13 Birmingham

Sep 20, 2024
pulisher
Sep 20, 2024

MBIO’s Stock Tango: The Dance of Gains and Losses in 2023 - The InvestChronicle

Sep 20, 2024
pulisher
Sep 20, 2024

Daily Market Movement: Mustang Bio Inc (MBIO) Sees a -12.17 Decrease, Closing at 0.22 - The Dwinnex

Sep 20, 2024
pulisher
Sep 20, 2024

Review: The striking, confident 2025 Ford Mustang, reimagined for the modern era - MarketWatch

Sep 20, 2024
pulisher
Sep 19, 2024

DEADLINE ALERT for OM, SAGE, and SMCI: The Law Offices of - GlobeNewswire

Sep 19, 2024
pulisher
Sep 19, 2024

Drugmaker for rare disease soars 1,200% in last year - Kursiv Media

Sep 19, 2024
pulisher
Sep 18, 2024

Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire

Sep 18, 2024
pulisher
Sep 18, 2024

Worcester biopharma faces delisting from Nasdaq - Worcester Business Journal

Sep 18, 2024
pulisher
Sep 18, 2024

Bokf Na Purchases 2,755 Shares of USANA Health Sciences, Inc. (NYSE:USNA) - Defense World

Sep 18, 2024
pulisher
Sep 17, 2024

As Interest in EVs Ebbs, Ford Reveals its Fastest, Most Powerful Mustang Ever- the 2025 Mustang GTD - Torque News

Sep 17, 2024
pulisher
Sep 17, 2024

Ford To Roll Out Limited Edition Street Legal Race Car Variant Of Mustang As Early As This Year - MSN

Sep 17, 2024
pulisher
Sep 16, 2024

The 2025 Mustang GTD Is Here, And It's The Most Powerful In History - MSN

Sep 16, 2024

Mustang Bio Inc Azioni (MBIO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Capitalizzazione:     |  Volume (24 ore):